Estimating Hypothetically Negotiated Royalty Rates After MedImmune, Inc. v Genentech, Inc. et al
$25.00v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
Showing all 2 results
v14i3: pp. 43-52 Stenan D. Porter Antitrust 2008
v11i2: pp. 61-80 W Cris Lewis; Frank N Caliendo; Tyler J Bowles; Misc-Not classified 2001
No products in the cart.